Table 2. The effect of NACT on surgery and histopathologic characteristics in patients with cervical cancer.
Item | NACT (n = 68) | PST (n = 42) | P a | |
Surgery characteristic | Estimated blood loss (mL) | 1061 ± 728 | 932 ± 537 | 0.324 |
The number of lymph nodes removed | 29.5 ± 11.6 | 31.6 ± 10.5 | 0.342 | |
Operation time (min) | 247 ± 68 | 240 ± 89 | 0.634 | |
Complications | 4 | 2 | 1.000 | |
Pathologic characteristic | Deep stromal invasion | 40 | 26 | 0.842 |
Parametrial involvement | 3 | 1 | 1.000 | |
Vaginal margin involvement | 5 | 3 | 1.000 | |
LVSI | 21 | 22 | 0.021 | |
Lymph node metastasis | 21 | 11 | 0.669 |
NACT, neoadjuvant chemotherapy; PST, primary surgery treatment; LVSI, lymph-vascular space involvement. aThe estimated blood loss, number of lymph nodes removed, and operation time were all tested by ANOVA. The Chi-square test was used to test the deep stromal invasion, parametrial involvement, vaginal margin involvement, LVSI, and lymph node metastasis rate.